OBIO logo

OBIO Free Cash Flow

Annual FCF

-$46.20 M
-$16.32 M-54.64%

December 31, 2023


Summary


Performance

OBIO Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOBIOcash flowmetrics:

Quarterly FCF

-$13.77 M
-$3.46 M-33.50%

September 30, 2024


Summary


Performance

OBIO Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOBIOcash flowmetrics:

TTM FCF

-$48.17 M
-$3.47 M-7.75%

September 30, 2024


Summary


Performance

OBIO TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOBIOcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

OBIO Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-54.6%-33.7%-9.4%
3 y3 years-72.9%-56.5%-61.2%
5 y5 years-72.9%-56.5%-61.2%

OBIO Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-134.5%at low-156.3%+4.5%-796.9%at low
5 y5-year-134.5%at low-156.3%+4.5%-796.9%at low
alltimeall time-134.5%at low-156.3%+4.5%-796.9%at low

Orchestra BioMed Holdings Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.77 M(+33.5%)
-$48.17 M(+7.8%)
Jun 2024
-
-$10.31 M(-21.4%)
-$44.71 M(-0.5%)
Mar 2024
-
-$13.12 M(+19.6%)
-$44.91 M(-2.8%)
Dec 2023
-$46.20 M
-$10.97 M(+6.5%)
-$46.20 M(+4.9%)
Sep 2023
-
-$10.30 M(-2.1%)
-$44.03 M(+6.8%)
Jun 2023
-
-$10.52 M(-27.0%)
-$41.21 M(+5.9%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$14.42 M(+63.9%)
-$38.92 M(+30.3%)
Dec 2022
-$29.88 M(+51.7%)
-$8.80 M(+17.6%)
-$29.88 M(+41.7%)
Sep 2022
-
-$7.48 M(-9.1%)
-$21.08 M(+55.0%)
Jun 2022
-
-$8.23 M(+53.2%)
-$13.60 M(+153.2%)
Mar 2022
-
-$5.37 M
-$5.37 M
Dec 2021
-$19.70 M(-26.3%)
-
-
Dec 2020
-$26.72 M
-
-

FAQ

  • What is Orchestra BioMed Holdings annual free cash flow?
  • What is the all time high annual FCF for Orchestra BioMed Holdings?
  • What is Orchestra BioMed Holdings annual FCF year-on-year change?
  • What is Orchestra BioMed Holdings quarterly free cash flow?
  • What is the all time high quarterly FCF for Orchestra BioMed Holdings?
  • What is Orchestra BioMed Holdings quarterly FCF year-on-year change?
  • What is Orchestra BioMed Holdings TTM free cash flow?
  • What is the all time high TTM FCF for Orchestra BioMed Holdings?
  • What is Orchestra BioMed Holdings TTM FCF year-on-year change?

What is Orchestra BioMed Holdings annual free cash flow?

The current annual FCF of OBIO is -$46.20 M

What is the all time high annual FCF for Orchestra BioMed Holdings?

Orchestra BioMed Holdings all-time high annual free cash flow is -$19.70 M

What is Orchestra BioMed Holdings annual FCF year-on-year change?

Over the past year, OBIO annual free cash flow has changed by -$16.32 M (-54.64%)

What is Orchestra BioMed Holdings quarterly free cash flow?

The current quarterly FCF of OBIO is -$13.77 M

What is the all time high quarterly FCF for Orchestra BioMed Holdings?

Orchestra BioMed Holdings all-time high quarterly free cash flow is -$5.37 M

What is Orchestra BioMed Holdings quarterly FCF year-on-year change?

Over the past year, OBIO quarterly free cash flow has changed by -$3.47 M (-33.66%)

What is Orchestra BioMed Holdings TTM free cash flow?

The current TTM FCF of OBIO is -$48.17 M

What is the all time high TTM FCF for Orchestra BioMed Holdings?

Orchestra BioMed Holdings all-time high TTM free cash flow is -$5.37 M

What is Orchestra BioMed Holdings TTM FCF year-on-year change?

Over the past year, OBIO TTM free cash flow has changed by -$4.14 M (-9.41%)